Skip to main content
. 2023 Oct 5;31:100733. doi: 10.1016/j.omto.2023.100733

Table 3.

CRISPR screens in other immune cells to enhance their anti-tumor reactivity

Species Target cells Loss or gain of function CRISPR library Transduction methods Selection methods Genes identified Corresponding proteins Gene/protein functions Years and references
Mouse raw macrophage cell line 264.7 loss of function self-designed library with 7272 sgRNA targeting classical RBP genes lentivirus transduction TNF-α production Mettl3 METTL3 METTL3-mediated m6A modification of Irakm mRNA accelerates its degradation, resulting in reprogramming macrophages for activation. Tong et al. (2021)113
cDC1s loss of function self-designed functional CRISPR library retrovirus transduction OVA cross-presentation Wdfy4 WDFY4 Loss of function of BEACH domain–containing protein Wdfy4 substantially impaired cross-presentation of cell-associated antigens by cDC1s in mice. Theisen et al. (2018)114
Human IL-2 dependent NK cell line NK-92 gain of function self-designed library with 22 gRNAs using Benchling’s CRISPR Design tool Cas RNP nucleofection calcein-AM cytotoxic assay FCGR3A FCGR3A Cas9-mediated promoter insertion effectively reactivated the endogenous FCGR3A and CD226 enhanced NK-92 cytotoxicity. Huang et al. (2020)111
CD226 CD226
moDC loss of function Brunello electroporation of in vitro-assembled Cas9-sgRNA complexes loss of TNF-α secretion TLR2 TLR2 TLR2 knockout caused decrease in TNF-α secretion. Jost et al. (2021)115
PTPN6/SHP-1 PTPN6 PTPN6 knockout strongly increased TNF-α secretion and moderately decreased IL-10 secretion.
human myeloid cell line U937 loss of function self-designed 10-sgRNA-per-gene CRISPR-Cas9 deletion library lentivirus transduction phagocytosis ability NHLRC2 NHLRC2 NHLRC2 negatively regulates RHOA, enabling RAC1-mediated cytoskeletal changes that are critical for phagocytosis. Haney et al. (2018)116
ELOVL1 ELOVL1 ELOVL1 gene disruption causes significant decrease in phagocytosis.
TM2D3 TM2D3 TM2D2- and TM2D3-deficient cells show impaired clearance of amyloid-β aggregates.

cDC1, classical dendritic cell; ELOVL1, elongation of very long chain fatty acids protein 1; FCGR3A, Fc gamma receptor IIIa; IL-2, interleukin-2; METTL3, methyltransferase 3; moDC, monocyte-derived dendritic cell; NHLRC2, NHL repeat containing protein 2; PTPN6, protein tyrosine phosphatase non-receptor type 6; TLR2, Toll-like receptor 2; TM2D3, TM2 domain containing 3; WDFY4, Wdfy family member 4.